Archive for Medication updates
Class 4 Medicines Defect Information: Ethigen Limited, Briviact 75mg & 100mg film-coated tablets, EL(23)A/13
Source: MHRA 30.3.23 Ethigen Limited have informed the MHRA that the Patient Information Leaflet (PIL) in Briviact 75mg and Briviact 100mg film coated tablets contains incorrect or missing information. MDR...
GnRH Analogues Update
We have updated our Brand Comparison page for GnRH Analogues. DISPEX Top Tips – Prostap MUST be obtained from……members click here to read in full! Looking to join Dispex, then...
Guidance on the HRT prescription prepayment certificate
Source: DHSC 24.3.23 Handling NHS HRT prescriptions This document provides guidance to GPs, prescribers, pharmacists and pharmacy staff on new procedures which have been developed following the introduction of the...
NEWS FLASH: Our Drug Supply Page Has Been Updated
24th March 2023 Dispex will provide primary care focused updates on drug supply issues. Data will be taken from the SPS website on a weekly basis. Dispex members can login here to see the...
Class 2 Medicines Recall: Ferring Pharmaceuticals Limited, GONAPEPTYL Depot 3.75mg, Powder and solvent for suspension for injection, EL(23)A/12
Source: MHRA /Gov.uk 23.3.23 Ferring Pharmaceuticals Limited is recalling certain batches of GONAPEPTYL Depot 3.75mg due to a defect noticed in the seal of the needle wrapping for the CE-marked...
Class 3 Medicines Recall: Rosemont Pharmaceuticals Limited, Sildenafil 10mg/ml Oral Suspension, EL(23)A/11
Source: MHRA / Gov.uk 21.3.23 Rosemont Pharmaceuticals Limited has informed the MHRA that the Press In Bottle Adaptor (PIBA) supplied with the pack (carton) in the batch listed above is...
HRT on Pre-Payment Certificates (PPC)
From 1 April 2023, women prescribed HRT – the main treatment for menopause symptoms – will have access to a new scheme enabling access to a year’s worth of menopause...
Class 2 Medicines Recall: Various Marketing Authorisation Holders, pholcodine-containing products, EL (23)A/09
Source: MHRA 15.3.23 Following the conclusion of a review of post-marketing safety data by the MHRA, all pholcodine-containing medicines are being recalled and withdrawn from the UK as a precaution....
Discount Updates March 2023: Daiichi-Sankyo-Lixiana (Edoxaban)
Published: 08 Mar 2023 Daiichi-Sankyo – Lixiana (Edoxaban) is becoming a solus product available from Alliance ONLY from 1 May 2023. All existing customers who had signed up for the Lixiana...
Class 4 Medicines Defect Information: Drugsrus Limited, Clexane 10,000 IU (100mg) / 1ml Syringes, EL(23)A/08
Source: MHRA / Gov.uk 9.3.23 Drugsrus Limited has informed the MHRA that the Patient Information Leaflet (PIL) packaged in specific batches of Clexane 10,000IU (100mg)/1 ml Syringes contains a typographical...
Class 4 Medicines Defect Information: Thornton & Ross Ltd, Methadone 1mg/mL Oral Solution BP – Sugar Free, Methadone Mixture 1mg/ml , EL(23)A/07
Source: MHRA/ Gov.uk 7.3.23 Thornton & Ross Ltd has informed the MHRA that specific batches of Methadone 1mg/mL Oral Solution BP Sugar Free and Methadone Mixture 1mg/ml, have been packaged...
Our Drug Supply Page Has Been Updated: 3rd March 2023
Dispex will provide primary care focused updates on drug supply issues. Data will be taken from the SPS website on a weekly basis. Dispex members can login here to see the updated...
